Britain approved Pfizer Inc's COVID-19 vaccine on Wednesday, jumping ahead of the rest of the world in the race to begin the most crucial mass inoculation programme in history.

Canada could approve Pfizer's COVID-19 vaccine "around December," about the same time as the United States and the European Union, a senior official at Canada's drug regulator said on Thursday.

Data demonstrated that vepdegestrant maintained patients’ quality of life for statistically significantly longer and delayed worsening of ...

Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

Dato-DXd showed a 43% reduction in disease progression risk and a 21% reduction in death risk compared to chemotherapy in TNBC patients ineligible for immunotherapy. The TROPION-Breast02 trial ...

Findings point to importance of RSV vaccination in older patients with systemic autoimmune rheumatic diseases.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Supernus Pharmaceuticals (NASDAQ:SUPN ...

Merck’s MRK shares have risen almost 13% in the past week as Pfizer’s PFE landmark deal with the Trump administration to ...

Dr Philip Mease explores how modern imaging tools are reshaping the understanding of joint damage and progression in ...

After weeks of confusion, approval by CDC and its acting director mean most Nebraskans can get COVID-19 vaccines after consulting with a health care provider, including pharmacists.

President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip ...